Analysis:

## (a) Source Analysis

**ECDC/ERVISS Sources:**
- Multiple ECDC articles describe ERVISS dashboard and data infrastructure (Jan 2026, high quality official sources)
- Confirm the SARITestsDetectionsPositivity.csv dataset exists and is actively maintained
- No actual test positivity data provided in these administrative documents
- **Factual**: ERVISS is the official EU/EEA respiratory surveillance system

**UK Surveillance Reports (Jan 2026):**
- Three reports covering weeks 2-4 of 2026 (Jan 5-25, 2026)
- High quality official data from UKHSA
- Week 2: 1.6% SARS-CoV-2 positivity (hospital settings)
- Week 3: 1.8% positivity (up from 1.7%)
- Week 4: 1.8% positivity (stable)
- Assessment: "COVID-19 activity remained stable and is circulating at baseline levels"
- **Factual data**, but UK-specific, not EU/EEA. UK patterns often correlate with European trends but are not identical.

**UK Week 41, 2025 Report (Oct 2025):**
- Historical context: 12.9% positivity in hospital settings (Oct 2025)
- Shows autumn 2025 had higher positivity than current winter levels
- Indicates positivity has declined from autumn to winter
- **Factual**, suggests no sustained upward trajectory entering winter 2026

**AskNews Articles (Feb 11, 2026):**
- Multiple articles on measles outbreaks in Europe (not SARS-CoV-2)
- One Greek EODY report (Dec 1-7, 2025): "SARS-CoV-2 cases remain stable" with 104 hospital admissions
- **Expert opinion from ECDC officials**: Measles concerns, but no mention of COVID-19 acceleration
- Italian RespiVirNet (Nov 24-30, 2025): SARS-CoV-2 positivity at 4.0% among tested samples
- **Factual but limited relevance**: Different surveillance systems, different time periods

**Influenza Surveillance Articles (Nov-Dec 2025):**
- ECDC warnings about early influenza season (3-4 weeks earlier than usual)
- Driven by A(H3N2) subclade K
- **Factual**: Influenza is surging early, but this is distinct from SARS-CoV-2 patterns
- No evidence that COVID-19 is following similar early surge pattern

**Wastewater Surveillance (Sept-Oct 2025):**
- Greek report: SARS-CoV-2 positivity increased compared to previous week (late Sept 2025)
- French expansion of wastewater surveillance to other viruses
- **Weak evidence**: Single week increases don't predict sustained four-week streaks

## (b) Evidence Analysis

**Strong Evidence:**
- None directly addressing EU/EEA SARS-CoV-2 test positivity trends for 2026

**Moderate Evidence:**
- UK surveillance data (Weeks 2-4, 2026): Shows stable baseline positivity (1.6-1.8%), not accelerating. While UK-specific, it's a reliable proxy for broader European patterns. **Direction: Against sustained increases**
- Greek EODY report (Dec 2025): "SARS-CoV-2 cases remain stable" **Direction: Against sustained increases**
- Historical pattern (Oct 2025 â†’ Jan 2026): Positivity declined from 12.9% (UK, Oct) to 1.6-1.8% (UK, Jan), showing downward trajectory entering winter **Direction: Against sustained increases**

**Weak Evidence:**
- Italian RespiVirNet (Nov 2025): 4.0% positivity in limited sample
- Single-week increases in Greek wastewater (Sept 2025)
- Influenza surge: While respiratory viruses are active, influenza patterns don't necessarily predict COVID patterns

**Critical Gap:** No direct EU/EEA SARS-CoV-2 test positivity data from ERVISS for recent weeks. All evidence is from proxy sources (UK) or different surveillance systems.

## (c) Timeframe Analysis

**Prediction Timeframe:** 
- Today: Feb 11, 2026
- Resolution: May 1, 2026
- Duration: 11 weeks remaining

**Current Position in Respiratory Season:**
- Mid-February is typically peak or late-peak winter respiratory season
- UK data shows we're at baseline, not in an accelerating wave
- If a winter wave were building, evidence would likely be visible by now

**If Timeframe Halved (5.5 weeks, to ~March 20):**
- Would reduce probability significantly (perhaps to 15-20%)
- Less time for a new wave to develop and sustain four consecutive increases
- We're already past typical peak timing

**If Timeframe Doubled (22 weeks, to ~July 2026):**
- Would increase probability moderately (perhaps to 35-40%)
- Would capture potential late winter/spring wave and early summer uptick
- More opportunities for four-week streaks across different seasonal patterns

## (d) Justification

**Factors Shifting Prediction DOWN from 28% outside view:**

1. **Current stable baseline (Moderate evidence):** UK shows 1.6-1.8% positivity with explicit assessment of "baseline levels" and "stable" activity. This is not the profile of an accelerating wave. For a four-week streak to occur, we'd need to transition from stable baseline to sustained acceleration quickly.

2. **Timing within respiratory season (Moderate evidence):** We're mid-February, typically at or past peak winter respiratory activity. Historical COVID patterns show winter peaks in December-January. Starting a sustained four-week increase in mid-February would be atypical.

3. **Recent trajectory is downward (Moderate evidence):** UK data shows decline from 12.9% (Oct 2025) to 1.6% (Jan 2026), suggesting the autumn wave has resolved without transitioning to a winter wave.

4. **Stringent criteria (Structural factor):** Four consecutive week-over-week increases requires monotonic growth without any weekly decline. Even during waves, positivity often plateaus or dips week-to-week due to testing patterns, reporting delays, or natural fluctuation.

**Factors Shifting Prediction UP from 28% outside view:**

1. **Reasonable timeframe (Weak-Moderate):** 11 weeks provides multiple opportunities for a four-week streak if conditions change

2. **Endemic variability (Weak):** COVID-19 in endemic phase can still show localized or variant-driven increases, though less dramatic than pandemic era

**Net Assessment:**
The moderate evidence of current stability and unfavorable timing within the respiratory season outweighs the weak positive factors. The outside view of 28% already accounts for the possibility of a late winter/spring wave. Current evidence suggests we're not in the early stages of such a wave, which should shift the prediction downward.

Probability calibration:

Starting from outside view base rate of 28%, I adjust downward based on:
- Current stable baseline in available proxy data (UK, Greece)
- Unfavorable timing (mid-February, past typical peak)
- Downward trajectory from autumn to winter
- Stringent nature of "four consecutive" increases

These factors suggest the probability is lower than the outside view, which was calibrated for a "typical" winter period. We're now in a specific winter period with observable stable conditions.

**Calibrated Inside View:** 18-22% range

The 11-week timeframe prevents going too low (there's still time for unexpected developments), but current evidence argues against the base rate scenario.

Checklist:

1. **Paraphrase:** Will EU/EEA SARS-CoV-2 test positivity (ECDC data) show four consecutive weekly increases before May 1, 2026?

2. **Outside view base rate:** 28% - calibrated for endemic COVID during winter respiratory season with 11-week window

3. **Consistency check:** "20 out of 100 times, EU/EEA test positivity shows four consecutive weekly increases in an 11-week mid-February to May period during endemic phase." This aligns with low but non-negligible probability given current stable conditions but remaining time.

4. **Key evidence:**
   - UK surveillance (Jan 2026): Stable 1.6-1.8% positivity at baseline levels (factual, high quality)
   - Greek EODY (Dec 2025): SARS-CoV-2 cases remain stable (factual, official)
   - Seasonal timing: Mid-February, past typical winter peak (structural)
   - Trajectory: Decline from 12.9% (Oct) to 1.6% (Jan) in UK (factual, high quality)
   - Stringent criteria: Four consecutive increases without any weekly decline (definitional)

5. **Blind-spot:** A new variant with immune escape properties emerges in late February/March, driving rapid transmission acceleration across EU/EEA. This could create sustained increases. However, no current evidence of such variant emergence. This scenario might push probability to 40-50%.

6. **Status quo:** Current status quo is stable baseline circulation. Continuing this trend means no four-week streak occurs. Given low volatility in recent weeks and endemic phase characteristics, status quo continuation is likely. This supports a probability below the outside view base rate.

Probability: 20%